Хайлтын үр дүнгүүд - Yin‐Hsun Feng
- 13-н 1 - 13 үр дүнгүүдийг харуулж байна
-
1
Emerging role of microRNA-21 in cancer -н Yin‐Hsun Feng, Chao‐Jung Tsao
Хэвлэсэн 2016Artigo -
2
-
3
-
4
-
5
Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression -н Yu-Chu Su, Yin‐Hsun Feng, Hung‐Tsung Wu, Yao-Shen Huang, Chao-Ling Tung, Pensée Wu, Chih‐Jen Chang, Ai‐Li Shiau, Chao‐Liang Wu
Хэвлэсэн 2018Artigo -
6
Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: Correlation with the clinical stage of the disease -н Yin‐Hsun Feng, Chao‐Liang Wu, Chao-Jung Tsao, Jan‐Gowth Chang, Pei‐Jung Lu, Kun-Tu Yeh, Yih‐Huei Uen, Jeng-Chang Lee, Ai‐Li Shiau
Хэвлэсэн 2011Artigo -
7
Frequent association of malignant effusions in plasmablastic lymphoma: a single-institutional experience of nine cases in Taiwan -н Bo‐Jung Chen, Yu‐Ting Kuo, Sheng‐Tsung Chang, Khin-Than Win, Shang‐Wen Chen, Sheng‐Yen Hsiao, Yin‐Hsun Feng, Yen-Chuan Hsieh, Shih‐Sung Chuang
Хэвлэсэн 2025Artigo -
8
-
9
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study -н Shukui Qin, Zhenggang Ren, Yin‐Hsun Feng, Thomas Yau, Baocheng Wang, Haitao Zhao, Yuxian Bai, Shanzhi Gu, Lindong Li, Sairy Hernandez, Derek-Zhen Xu, Sohail Mulla, Yifan Wang, Hui Shao, Ann‐Lii Cheng
Хэвлэсэн 2021Artigo -
10
Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer -н Chia-Sing Lu, Ai‐Li Shiau, Bing-Hua Su, Tsui-Shan Hsu, Chung-Teng Wang, Yu-Chu Su, Ming-Shian Tsai, Yin‐Hsun Feng, Yau‐Lin Tseng, Yi‐Ting Yen, Chao‐Liang Wu, Gia-Shing Shieh
Хэвлэсэн 2020Artigo -
11
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma -н Ghassan K. Abou‐Alfa, Shukui Qin, Baek‐Yeol Ryoo, Sheng‐Nan Lu, C-J. Yen, Yin‐Hsun Feng, Ho Yeong Lim, Francesco Izzo, M. Colombo, Debashis Sarker, Luigi Bolondi, Gina M. Vaccaro, William Proctor Harris, Z. Chen, Richard Hubner, Tim Meyer, Weijing Sun, James J. Harding, Ellen Hollywood, Jennifer Ma, Peter J. Wan, Michele Ly, John S. Bomalaski, A. E. Johnston, C.-C. Lin, Yee Chao, Liqun Chen
Хэвлэсэн 2018Artigo -
12
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial -н Cristina Saura, Mafalda Oliveira, Yin‐Hsun Feng, Ming‐Shen Dai, Shang-Wen Chen, Sara A. Hurvitz, Sung‐Bae Kim, Beverly Moy, Suzette Delaloge, William J. Gradishar, Norikazu Masuda, Markéta Palácová, Maureen Trudeau, Johanna Mattson, Yoon Sim Yap, Ming‐Feng Hou, Michelino De Laurentiis, Yu‐Min Yeh, Hong‐Tai Chang, Thomas Yau, Hans Wildiers, Barbara Haley, Daniele Fagnani, Yen‐Shen Lu, John Crown, Johnson Lin, Masato Takahashi, Toshimi Takano, Miki Yamaguchi, Takaaki Fujii, Bin Yao, Judith D. Bebchuk, Kiana Keyvanjah, Richard Bryce, Adam Brufsky
Хэвлэсэн 2020Artigo -
13
Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study -н Miguel Martín, Elgene Lim, Mariana Chávez‐MacGregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, R. N. Safin, Sung‐Bae Kim, Christian Schem, Alberto J. Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M. Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Perez-Moreno, Joohyuk Sohn, G. Aguil, Marcos E. Alfie, Valeria Cáceres, Guillermo Lerzo, Sandra A. Ostoich, F. Boyle, Elgene Lim, Hayes Martin, Catherine Oakman, Felipe Melo Cruz, Fábio Franke, André Mattar, E.H. Silva, Katsuki Arima Tiscoski, Wei Chen, Wěi Li, Zhongsheng Tong, Jing Wang, Shaomeng Wang, X. Wang, Jiong Wu, Xiao‐Yuan Wu, Ju Yang, Q. Zhang, Till‐Oliver Emde, G. Gaffunder, Carsten Hielscher, Michael P. Lux, Christian Schem, Manfred Welslau, Claudia Schumacher, I. Kuchuk, T Peretz, Larisa Ryvo, R. Yerushalmi, Hee Dong Chae, Y.S. Chae, Seock‐Ah Im, Hwa Jung Kim, Jie‐Hyun Kim, S.-B. Kim, Jung Eun Lee, Y. H. Park, Joohyuk Sohn, Michał Jarząb, Monika Nowaczyk, Zbigniew Nowecki, Tadeusz Pieńkowski, Marek Z. Wojtukiewicz, Piotr J. Wysocki, E. Fomin, I. P. Ganshina, Nikolay Kislov, М. В. Копп, Н. В. Коваленко, Y. Makarova, Marina Matrosova, Р. В. Орлова, Artem Poltoratsky, Р. Р. Сафин, Р. А. Зуков, A. Wong, Yoon Sim Yap, M.A. Coccia-Portugal, Nicolaas H. Fourie, R. Khanyile, L. Schoeman, Ta‐Chung Chao, S.-T. Chen, Wei‐Pang Chung, Yin‐Hsun Feng, Yung‐Chang Lin, Thitiya Dejthevaporn, Napa Parinyanitikul, Chirawadee Sathitruangsak, Areewan Somwangprasert, Piyawan Tienchaianada, Ahmet Alacacıoğlu, Efnan Algın
Хэвлэсэн 2024Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Cancer
Internal medicine
Medicine
Cancer research
Gastroenterology
Oncology
Biology
Clinical endpoint
Gene
Hepatocellular carcinoma
Biochemistry
Breast cancer
Carcinogenesis
Chemotherapy
Confidence interval
Hazard ratio
Pathology
Randomized controlled trial
Atezolizumab
Bevacizumab
Cancer cell
Cell biology
Cell cycle
Clinical trial
Colorectal cancer
Disease
Downregulation and upregulation
Endocrinology
Genetics
Immunology